Claims
- 1. An isolated nucleic acid comprising a sequence that encodes:a protein comprising an amino acid sequence of SEQ ID NO: 6.
- 2. A vector comprising:a sequence that encodes a polypeptide with an amino acid sequence of SEQ ID NO: 6.
- 3. A transformed cell comprising:a vector comprising a sequence that encodes a polypeptide with an amino acid sequence of SEQ ID NO: 6.
- 4. A transformed cell comprising:a first vector comprising a sequence that encodes a first polypeptide with an amino acid sequence of SEQ ID NO: 6 for converting a first compound into a second compound; a second vector comprising a sequence that encodes a second polypeptide for converting the second compound into a third compound; and a third vector comprising a sequence that encodes a third polypeptide for converting the third compound into a fourth compound.
- 5. The transformed cell according to claim 4 wherein the first, second, and third compounds are sulfur compounds; and the fourth compound is a desulfurized compound.
- 6. The transformed cell according to claim 4 wherein the first compound comprises dibenzothiophene; the second compound comprises dibenzothiophenesulfone; the third compound comprises 2-(2′-hydroxyphenyl) benzenesulfinic acid; and the fourth compound comprises 2-hydroxylbiphenyl.
- 7. A transformed cell according to claim 4 wherein the; the second polypeptide comprises an amino acid sequence of SEQ ID NO: 2; and third polypeptide comprises an amino acid sequence of SEQ ID NO: 4.
- 8. The transformed cell according to claim 4, wherein the second polypeptide has the following characteristics:(1) Function: it converts dibenzothiophenesulfone into 2-(2′-hydroxyphenyl) benzenesulfinic acid (2) Optimum pH: 5.5, stable pH: 5-10; (3) Optimum temperature: 45° C. (4) Molecular weight: 120,000 (as determined by gel filtration); (5) Inhibition of activity: it is inhibited by chelating agents or SH inhibitors, but no by 2-HBP or sulfate; and (6) Requirement for coenzyme: NADH and FMN are required; NADPH can be substituted for NADH, but FAD cannot be substituted for FMN.
- 9. The transformed cell according to claim 4, wherein the third polypeptide has the following characteristics:(1) Function: 2-(2′-hydroxyphenyl) benzenesulfinic acid into 2-hydroxylbiphenyl; (2) Optimum pH: 8, stable pH: 5.5-9.5; (3) Optimum temperature: 55° C.; (4) Molecular weight: 31,000 (as determined by gel filtration); (5) Inhibition of activity: it is inhibited by chelating agents and SH inhibitors, but not by 2-HBP or sulfate; and (6) Requirement for coenzyme; coenzyme is not required.
- 10. A process of producing polypeptides comprising:expressing in the transformed cell of claim 4, the first polypeptide to convert the first compound into the second compound; expressing in the transformed cell the second polypeptide to convert the second compound into the third compound; and expressing in the transformed cell the third polypeptide to convert the third compound into the fourth compound.
- 11. A process of producing polypeptides comprising:expressing in the transformed cell of claim 4, the first polypeptide to convert dibenzothiophene into dibenzothiophenesulfone; expressing in the transformed cell the second polypeptide to convert dibenzothiophenesulfone into 2-(2′-hydroxyphenyl) benzenesulfinic acid; and expressing in the transformed cell the third polypeptide to convert 2-(2′-hydroxyphenyl) benzenesulfinic acid into 2-hydroxylbiphenyl.
- 12. A process of producing a transformed cell comprising:providing into a cell a first vector comprising a sequence that encodes a first polypeptide with an amino acid sequence of SEQ ID NO: 6 to convert a first compound into a second compound; providing into the cell a second vector comprising a sequence that encodes a second polypeptide to convert the second compound into a third compound; and providing into the cell a third vector comprising a sequence that encodes a third polypeptide to convert the third compound into a fourth compound.
- 13. The process according to claim 12 wherein the first compound comprises dibenzothiophene; the second compound comprises dibenzothiophenesulfone; the third compound comprises 2-(2′-hydroxyphenyl) benzemesulfinic acid; and the fourth compound comprises 2-hydroxylbiphenyl.
- 14. A process of producing a transformed cell according to claim 12 wherein:the second polypeptide comprises an amino acid sequence of SEQ ID NO: 2; and the third polypeptide comprises an amino acid sequence of SEQ ID NO: 4.
- 15. The process according to claim 12, wherein the second polypeptide has the following characteristics:(1) Function: it converts dibenzothiophenesulfone into 2-(2′-hydroxyphenyl) benzenesulfinic acid (2) Optimum pH: 5.5, stable pH: 5-10; (3) Optimum temperature: 45° C. (4) Molecular weight: 120,000 (as determined by gel filtration); (5) Inhibition of activity: it is inhibited by chelating agents or SH inhibitors, but no by 2-HBP or sulfate; and (6) Requirement for coenzyme: NADH and FMN are required; NADPH can be substituted for NADH, but FAD cannot be substituted for FMN.
- 16. The process according to claim 12, wherein the third polypeptide has the following characteristics:(1) Function: 2-(2′-hydroxyphenyl) benzenesulfinic acid into 2-hydroxylbiphenyl; (2) Optimum pH: 8, stable pH: 5.5-9.5; (3) Optimum temperature: 55° C.; (4) Molecular weight: 31,000 (as determined by gel filtration); (5) Inhibition of activity: it is inhibited by chelating agents and SH inhibitors, but not by 2-HBP or sulfate; and (6) Requirement for coenzyme; coenzyme is not required.
- 17. The process according to claim 12 wherein the first, second, and third compounds are sulfuir compounds; and the fourth compound is a desulfurized compound.
Priority Claims (2)
Number |
Date |
Country |
Kind |
10-090387 |
Apr 1998 |
JP |
|
10-310545 |
Oct 1998 |
JP |
|
Parent Case Info
This is a divisional application of U.S. patent application No. 09/647,540, filed Sep. 29, 2001 now U.S. Pat. No. 6,420,158 which was the National Stage of International Application No. A PCT/JP99/01756, filed Apr. 2, 1999, which in turn claims the benefit of Japanese Application No. 090387/1998, filed Apr. 2, 1998, and Japanese Application No. 310545/1998, filed Oct. 30, 1998.
Foreign Referenced Citations (1)
Number |
Date |
Country |
10036859 |
Feb 1998 |
JP |
Non-Patent Literature Citations (4)
Entry |
Sequence search alignment between applicants SEQ ID NO: 1 and accession U08850.* |
Denome et al. (1994) Characterization of the Desulfurization Genes from Rhodococcus sp. Strain IGTS8, Journal of Bacteriology, vol. 176, No. 21, 6707-6716. |
Piddington et al. (1995) Sequence and Molecular Characterization of a DNA Region Encoding the Dibenzothiophene Desulfuization Operon of Rhodococcus sp. Strain IGTS8, vol. 61, No. 2, pp. 468-475, Applied micro (19. |
Konishi et al. (1997) Thermophilic Carbon-Sulfur-Bond-Targeted Biodesulfurization, vol. 63, No. 8, pp. 3164-3169 Appl. Environ. Microbiol. (1997). |